systems across the Middle East, North Africa, and South Asia. Modern biomedical research increasingly validates its pharmacological potential, attributing diverse therapeutic effects primarily to its bioactive compound thymoquinone. Findings suggest that Nigella sativa demonstrates significant therapeutic promise, although further standardized clinical trials are required to confirm dosage safety and long-term efficacy. Evidence from both in vitro, in vivo, and clinical research suggests that Nigella sativa demonstrates significant therapeutic potential across multiple physiological systems. However, despite promising results, challenges remain regarding dosage standardization, extraction methods, and the need for large-scale randomized clinical trials. The findings highlight the potential of Nigella sativa as a valuable natural therapeutic agent and emphasize the need for further research to establish standardized clinical applications.